HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lydia Scarfò Selected Research

BNT162 Vaccine

11/2022Six-month antibody persistence after BNT162b2 mRNA COVID-19 vaccination in patients with chronic lymphocytic leukemia.
10/2021Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lydia Scarfò Research Topics

Disease

42B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
03/2024 - 05/2010
8Neoplasms (Cancer)
11/2023 - 09/2013
5COVID-19
11/2022 - 01/2020
5Disease Progression
01/2022 - 11/2014
3Residual Neoplasm
01/2023 - 12/2022
3Lymphoma (Lymphomas)
01/2022 - 11/2015
2Inflammation (Inflammations)
03/2024 - 10/2017
2Infections
09/2022 - 01/2020
2Lymphocytosis
01/2021 - 12/2018
2Leukemia
01/2021 - 01/2018
2Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
03/2017 - 03/2015
2Hematologic Neoplasms (Hematological Malignancy)
04/2016 - 09/2013
1Psoriasis (Pustulosis Palmaris et Plantaris)
03/2024
1Multiple Sclerosis
03/2024
1Prostatic Neoplasms (Prostate Cancer)
11/2023
1Melanoma (Melanoma, Malignant)
11/2023
1Atrial Fibrillation
09/2022
1Diarrhea
09/2022
1Hemorrhage
01/2022
1Thrombosis (Thrombus)
01/2022
1Agammaglobulinemia (Hypogammaglobulinemia)
07/2021
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2021
1Mycoses (Diseases, Fungus)
01/2020
1Invasive Fungal Infections
01/2020
1Neoplasm Metastasis (Metastasis)
11/2019
1Tissue Adhesions
01/2018
1Melena
03/2017
1Infarction (Infarctions)
03/2017
1Vomiting
03/2017
1Stroke (Strokes)
03/2017
1Febrile Neutropenia
03/2017
1Neutropenia
03/2017
1Hypoxia (Hypoxemia)
04/2016

Drug/Important Bio-Agent (IBA)

13ibrutinibIBA
03/2024 - 05/2018
8Immunoglobulins (Immunoglobulin)IBA
11/2023 - 11/2014
6Toll-Like Receptors (Toll-Like Receptor)IBA
03/2024 - 01/2013
6venetoclaxIBA
10/2023 - 01/2021
4Rituximab (Mabthera)FDA Link
11/2023 - 03/2015
3Agammaglobulinaemia Tyrosine KinaseIBA
12/2022 - 01/2021
3ofatumumabFDA Link
01/2022 - 12/2015
3Oxygen (Dioxygen)IBA
01/2022 - 01/2020
3Immunoglobulin M (IgM)IBA
01/2022 - 01/2014
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2023 - 12/2015
2Transcription Factors (Transcription Factor)IBA
10/2023 - 04/2016
2Messenger RNA (mRNA)IBA
11/2022 - 10/2021
2BNT162 VaccineIBA
11/2022 - 10/2021
2obinutuzumabIBA
01/2022 - 01/2020
2Lenalidomide (CC 5013)FDA Link
01/2022 - 03/2017
2Chlorambucil (Leukeran)FDA Link
01/2022 - 01/2020
2Proteins (Proteins, Gene)FDA Link
11/2019 - 10/2017
2ChemokinesIBA
10/2019 - 01/2018
1Dimethyl FumarateIBA
03/2024
1AntioxidantsIBA
03/2024
1Glutathione (Reduced Glutathione)IBA
03/2024
1fludarabineIBA
11/2023
1dimethyl itaconateIBA
10/2023
1Phosphotransferases (Kinase)IBA
01/2023
1ribonucleotide polymeraseIBA
01/2023
1AntigensIBA
01/2022
1fibrin fragment D (D-dimer)IBA
01/2022
1Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
01/2022
1AlbuminsIBA
01/2022
1Chimeric Antigen ReceptorsIBA
01/2022
1C-Reactive ProteinIBA
01/2022
1Antiviral Agents (Antivirals)IBA
01/2022
1COVID-19 VaccinesIBA
10/2021
1VaccinesIBA
07/2021
1acalabrutinibIBA
01/2021
1A-factor (Streptomyces)IBA
01/2021
1Monoclonal AntibodiesIBA
01/2021
1EpitopesIBA
01/2021
1Cysteine (L-Cysteine)FDA Link
01/2021
1Peptides (Polypeptides)IBA
01/2021
1Complementarity Determining Regions (Complementarity Determining Region)IBA
01/2021
1TrabectedinIBA
12/2019
1Bendamustine HydrochlorideFDA Link
10/2019
1idelalisibIBA
05/2018
1RetinoidsIBA
01/2018
1Tretinoin (Retinoic Acid)FDA LinkGeneric
01/2018
1Chemokine CXCL13IBA
01/2018
1Toll-Like Receptor 9IBA
11/2017
1LigandsIBA
11/2017
1Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
10/2017
1CalreticulinIBA
10/2017
1Antigen Receptors (Antigen Receptor)IBA
10/2017
1dinaciclibIBA
01/2017
1Chromogranin AIBA
07/2016
1Pentostatin (Nipent)FDA LinkGeneric
12/2015
1Immunoglobulin G (IgG)IBA
01/2014
1Immunoglobulin D (IgD)IBA
01/2014
1Proto-Oncogene Proteins c-bcl-2 (Proto Oncogene Proteins c bcl 2)IBA
09/2013
1MicroRNAs (MicroRNA)IBA
05/2010

Therapy/Procedure

10Therapeutics
01/2023 - 09/2013
2Immunotherapy
01/2021 - 01/2019
1Duration of Therapy
09/2022
1Palliative Care (Palliative Therapy)
11/2021
1Critical Care (Surgical Intensive Care)
01/2020
1Immunomodulation
12/2019
1Stem Cell Transplantation
03/2017
1Treatment Delay
08/2016